Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension

European Respiratory Journal

Volumn 40, Issue 6, 2012, Pages 1410-1419

  Deboeck, Gaël ^a   Scoditti, Cristina ^c   Huez, Sandrine ^a   Vachiéry, Jean Luc ^a   Lamotte, Michel ^a   Sharples, Linda ^d   Melot, Christian ^a   Naeije, Robert ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF BARI   (Italy)

^d PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

6 min walk test; Cardiopulmonary exercise testing; Clinical worsening; Pulmonary arterial hypertension; Pulmonary hypertension; Survival

Indexed keywords

CARBON DIOXIDE;

ADULT; ANAEROBIC THRESHOLD; ARTICLE; CARBON DIOXIDE TENSION; CARDIOPULMONARY EXERCISE TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HUMAN; IDIOPATHIC DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL; TIDAL VOLUME; TREATMENT OUTCOME; WALKING;

ADULT; AGED; CARBON DIOXIDE; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; WALKING;

EID: 84871223698     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00217911     Document Type: Article

References (33)

1. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. Circulation 2009; 119: 2250-2294.
2. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (ISHLT), et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-1263.
3. Sun XG, Hansen JE, Oudiz RJ, et al. Exercise pathophysiology in patients with pulmonary hypertension. Circulation 2001; 104: 429-435. (Pubitemid 32678273)
4. Naeije R. The 6-min walk distance in pulmonary arterial hypertension: "Je t'aime, moi non plus". Chest 2010; 137: 1258-1260.
5. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487-492. (Pubitemid 30129457)
6. Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-788.
7. Groepenhoff H, Vonk-Noordegraaf A, Boonstra A, et al. Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 2008; 40: 1725-1732.
8. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.
9. Humbert M, Sitbon O, Yaïci A, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010; 36: 549-555.
10. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122: 164-172.
11. McLaughlin VV, Badesch DB, Delcroix M, et al. End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S97-S107.
12. Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension. Importance of cardiopulmonary exercise testing. Circulation 2002; 106: 319-324. (Pubitemid 34778955)
13. Souza R, Humbert M, Sztrymf B, et al. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J 2008; 31: 343-348.
14. Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation, 4th Edn. Baltimore, Lippincott Williams & Wilkins, 2005.
15. Sun XG, Hansen JE, Oudiz RJ, et al. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation 2002; 105: 54-60. (Pubitemid 34049142)
16. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020-2027. (Pubitemid 16066969)
17. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
18. Chuang ML, Lin IF, Wasserman K. The body weight-walking distance product as related to lung function, anaerobic threshold and peak V′O2 in COPD patients. Respir Med 2001; 95: 618-626. (Pubitemid 32624529)
19. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009; 120: 992-1007.
20. Barst RJ, McGoon M, McLaughlin V. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2003; 41: 2119-2125. (Pubitemid 36724255)
21. Barst RJ, Langleben D, Frost A, et al. Sitaxsentran therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 2004; 169: 441-447. (Pubitemid 38187114)
22. Oudiz RJ, Barst RJ, Hansen JE, et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006; 9: 123-126. (Pubitemid 41828135)
23. Cooper KH. A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. JAMA 1968; 203: 135-138.
24. Deboeck G, Niset G, Vachiery JL, et al. Physiologic response to the 6MWT in pulmonary arterial hypertension. Eur Respir J 2005; 26: 667-672. (Pubitemid 41448666)
25. Chua TP, Ponikowski P, Harrington D, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997; 29: 1585-1590. (Pubitemid 27272454)
26. Kleber FX, Vietzke G, Wernecke KD, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000; 101: 2803-2809. (Pubitemid 30396010)
27. McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension. ACCP Evidence-Based Clinical Practice Guidelines. Chest 2004; 126: 78S-92S. (Pubitemid 38932344)
28. Oudiz RJ, Midde R, Hovenesyan A, et al. Usefulness of right-to-left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension. Am J Cardiol 2010; 105: 1186-1191.
29. 2 slope in patients with heart failure: a prognostic comparison. Am Heart J 2004; 147: 354-360.
30. Deboeck G, Niset G, Lamotte M, et al. Cardiopulmonary exercise testing in pulmonary arterial hypertension and in congestive heart failure. Eur Respir J 2004; 23: 747-751. (Pubitemid 38618147)
31. Johnson RL Jr. Gas exchange efficiency in congestive heart failure. II. Circulation 2001; 103: 916-918. (Pubitemid 32183794)
32. Naeije R, van de Borne P. Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. Eur Respir J 2009; 34: 792-794.
33. Avouac J, Kowal-Bielecka O, Pittrow D, et al. Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group. Ann Rheum Dis 2010; 69: 1360-1363.